Table 3.
Univariate Analysis of Patients in Terms of Postoperative Complications.
| Variable | Complication (+) (n = 34) |
Complication (−) (n = 111) |
P-value |
|---|---|---|---|
| Age (years) | 87 (85-94) | 87 (85-97) | NS |
| Sex (male/female) | 16/18 | 56/55 | NS |
| ASA 2/ASA 3 | 29/5 | 97/14 | NS |
| CEA | 4.3 (1.2-111.3) | 4.8 (0.9-2426.6) | NS |
| BMI | 20.6 (16.3-29.0) | 21.6 (14.9-33.3) | 0.081 |
| Heart disease (yes/no) | 1/33 | 1/110 | NS |
| Pulmonary disease (yes/no) | 2/32 | 2/109 | NS |
| Diabetes mellitus (yes/no) | 5/29 | 18/93 | NS |
| Laparoscopic surgery (yes/no) | 21/13 | 88/23 | 0.039 |
| Tumor location (C/A/T/D/S/R) | 1/8/3/3/7/12 | 16/30/12/6/26/21 | NS |
| TNM stage (0/I/II/III/IV) | 0/5/11/14/4 | 1/27/46/30/7 | NS |
| Operative time (min) | 182 (32-329) | 160 (52-482) | NS |
| Blood loss (mL) | 15 (0-642) | 5 (0-974) | NS |
| Surgical risk scoring system | |||
| E-PASS PRS | 0.5098 | 0.5059 | NS |
| (0.3579-1.2034) | (0.3579-1.1098) | ||
| E-PASS SSS | −0.1515 | −0.2035 | 0.005 |
| (−0.2600-0.4233) | (−0.2990-0.5933) | ||
| E-PASS CRS | 0.0919 | −0.0484 | 0.018 |
| (−0.2400-0.5623) | (−0.257-0.8788) | ||
| NLR | 2.687 | 2.777 | NS |
| (0.9483-12.608) | (1.0453-16.336) | ||
| PLR | 216.2 | 174.4 | NS |
| (60.818-487.18) | (53.939-718.21) | ||
| PNI | 42.415 | 44.295 | 0.076 |
| (22.375-53.525) | (25.005-57.81) | ||
| mGPS (0 and 1/2) | 32/2 | 108/3 | NS |
ASA, American Society of Anesthesiologists; CEA, carcinoembryonic antigen; BMI, body mass index; C/A/T/D/S/R: cecum/ascending/transverse/descending/sigmoid/rectum; E-PASS, Estimation of Physiologic Ability and Surgical Stress; PRS, preoperative risk score; SSS, surgical stress score; CRS, comprehensive risk score; NLR, neutrophil/lymphocyte ratio; PLR, platelet/lymphocyte ratio; PNI, prognostic nutritional index; mGPS, modified Glasgow Prognostic Score